2022 Q4 and Full Year highlights compared to the corresponding period of 2021: Fourth quarter revenue was $13.8 million, an increase of 20% Fourth quarter net income was $3.2 million, an increase of 113% Full year revenue was $56.7 million, an increase of 7% Full year net income was $14.3 million, a decrease of 17% […]

2022 Q3 quarterly HIGHLIGHTS compared to the corresponding period of 2021: Revenue was $14.0 million, same as the prior year period Net income was $3.7 million, or $0.55 per basic share and $0.46 per diluted share, compared to $4.2 million, or $0.61 per basic share and $0.51 per diluted share Cash and cash equivalents at September 30, 2022 increased to $45.5 million from $35.9 million SANTA CLARA, […]

2022 Q1 HIGHLIGHTS compared to the corresponding period of 2021: Revenues were $14.0 million, an increase of $0.8 million, or 6%, compared to $13.2 million Net income was $3.4 million, or $0.50 per basic share and $0.41 per diluted share, compared to $4.9 million, or $0.73 per basic share and $0.60 per diluted share Cash at March 31, 2022 increased to $38.4 million from $26.5 million SANTA CLARA, Calif., May […]

2021 Q1 HIGHLIGHTS compared to the corresponding period of 2020: – Revenues were $13.2 million, an increase of 40% – Pre-tax net income of $6.0 million, an increase of $2.5 million, or 74%, compared to $3.5 million – Net income was $4.9 million, or $0.73 per basic share and $0.60 […]

2020 HIGHLIGHTS compared to 2019: – Annual revenues increased by 18% – Pre-tax net income of $16.5 million, an increase of $5.8 million, or 54%, compared to $10.7 million – Net income of $14.0 million, a decrease of $1.1 million, or 7%, compared to $15.1 million (which included a $4.4 […]

SANTA CLARA, Calif., Nov. 12, 2020 /PRNewswire/ — Semler Scientific, Inc. (OTCQB: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced the appointment of Cindy Moon, a D.C.-based, healthcare payment policy expert, to its Board of Directors, effective November 10, 2020. With this addition, Semler’s […]

2020 Q3 HIGHLIGHTS compared to Q2 2020: – Revenues were $10,727,000, an increase of $4,354,000, or 68%, compared to $6,373,000 – Pre-tax net income of $5,595,000, an increase of $4,605,000, or 465%, compared to $990,000 – Net income was $4,866,000, or $0.74 per basic share and $0.61 per diluted share, […]

2020 Q1 HIGHLIGHTS compared to the corresponding period of 2019: – Revenues were $9,430,000, which is an increase of 39% – Pre-tax net income of $3,450,000, an increase of $1,596,000, or 86%, compared to $1,854,000 – Net income grew to $0.41 per basic share and $0.33 per diluted share, compared […]

SAN JOSE, Calif., Feb. 14, 2019 /PRNewswire/ — Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for fourth quarter and full year ended December 31, 2018 before the open of U.S. […]